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http://www.biomedcentral.com/1471-2466/14/34RESEARCH ARTICLE Open AccessThoracic gas compression during forced expiration
in patients with emphysema, interstitial lung
disease and obesity
Päivi L Piirilä1*, Ulla Hodgson2, Tomi Wuorimaa1, Hans-Jürgen Smith3 and Anssi RA Sovijärvi1Abstract
Background: Dynamic gas compression during forced expiration has an influence on conventional flow-volume
spirometry results. The extent of gas compression in different pulmonary disorders remains obscure. Utilizing a flow
plethysmograph we determined the difference between thoracic and mouth flows during forced expiration as an
indication of thoracic gas compression in subjects with different pulmonary diseases characterized by limitations in
pulmonary mechanics.
Methods: Patients with emphysema (N = 16), interstitial lung disease (ILD) (N = 15), obesity (N = 15) and healthy
controls (N = 16) were included. Compressed expiratory flow-volume curves (at mouth) and corresponding
compression-free curves (thoracic) were recorded. Peak flow (PEF) and maximal flows at 75%, 50% and 25% of
remaining forced vital capacity (MEF75, MEF50 and MEF25) were derived from both recordings. Their respective
difference was assessed as an indicator of gas compression.
Results: In all groups, significant differences between thoracic and mouth flows were found at MEF50 (p < 0.01). In
controls, a significant difference was also measured at MEF75 (p <0.005), in emphysema subjects, at PEF and MEF75
(p < 0.05, p < 0.005) and in obese subjects at MEF75 (p <0.005) and MEF25 (p < 0.01). ILD patients showed the
lowest difference between thoracic and mouth flows at MEF75 relative to controls and emphysema patients
(p < 0.005, p < 0.001). Obese subjects did not differ from controls, however, the difference between thoracic and
mouth flows was significantly higher than in patients with emphysema at MEF50 (p < 0.001) and MEF25
(p < 0.005).
Conclusions: Alveolar gas compression distorts the forced expiratory flow volume curve in all studied groups at
the middle fraction of forced expiratory flow. Consequently, mouth flows are underestimated and the reduction of
flow measured at 75% and 50% of vital capacity is often considerable. However, gas compression profiles in stiff
lungs, in patients with decreased elastic recoil in emphysema and in obesity differ; the difference between thoracic
and mouth flows in forced expiration was minimal in ILD at the first part of forced expiration and was higher in
obesity than in emphysema at the middle and last parts of forced expiration.
Keywords: Chronic obstructive pulmonary disease, Emphysema, Flow plethysmography, Healthy control,
Interstitial lung disease, Obesity, Thoracic gas compression* Correspondence: paivi.piirila@hus.fi
1Unit of Clinical Physiology, Department of Clinical Physiology and Nuclear
Medicine, HUS Medical Imaging Center, Helsinki University Central Hospital,
P.O. Box 340, Helsinki, HUS 00029, Finland
Full list of author information is available at the end of the article
© 2014 Piirilä et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited.
Piirilä et al. BMC Pulmonary Medicine 2014, 14:34 Page 2 of 9
http://www.biomedcentral.com/1471-2466/14/34Background
During forced expiration alveolar gas is compressed due
to muscular force and the combined effect of elastic
pressures of the thorax and lungs acting against airway
resistances [1]. The compression-free flow-volume curve
can be measured by a flow plethysmograph (transmural
plethysmograph), employed in a constant pressure,
pressure-corrected mode, by integrating air flow through
a pneumotachograph in the wall of a body plethysmo-
graph. A flow plethysmograph measures the volume dis-
placement of the chest movement simultaneously with
the spirometric measurement of integrated flow at the
mouth. This method permits accurate measurements of
changes in thoracic gas volume (TGV) during forced ex-
piratory manoeuvres [2,3].
Several reports exist on increased thoracic gas com-
pression in asthma, the compression increasing with
increasing airways resistance [4-6]. Alveolar gas com-
pression during forced expiration causes a considerable
artifact on flow-volume curves derived from mouth flow
[7-9]. This divergence is also seen in flow-volume loops
during bronchodilation testing, especially in the mid-
range of forced expiratory flow [5,6]. Elevated gas com-
pression at the mid-fraction of the forced expiratory
flow-volume loop has been reported for smoking sub-
jects [5] and in chronic obstructive pulmonary disease
(COPD) [10,11]. However, as far as we know, no data
are available on gas compression in interstitial lung dis-
ease (ILD) or obesity.
Gas compression can modify the results of conven-
tional forced spirometry. Therefore, we were interested
in studying gas compression in ILD and obesity relative
to healthy controls and patients with emphysema.
Thoracic gas compression was investigated in four groups
of subjects with different pulmonary mechanics: healthy
non-smoking subjects (controls), healthy non-smoking
obese subjects (obese), patients with interstitial lung disease
(ILD) and patients with emphysema (emphysema).
Patients
The anthropometric data and smoking habits of subjects
included in the study are summarized in Table 1. HealthyTable 1 Anthropometric data and smoking history of patient
Controls, N = 16 ILD, N = 15
Men/women 10/6 7/8
Weight (kg) 70.94 (9.54) (51 – 88) 71.65 (9.1) (5
Height (cm) 170.69 (6.05) (161 – 179) 169.0 (9.6) (1
BMI (kg/m2) 24.18 (2.30) (19.7 – 27.5) 25.0 (1.83) (2
Age (years) 65.06 (11.19) (35 – 79) 60.1 (11.1) (4
Smokers/ex-smokers 0/0 0/1
Smoking (pack- years) 0 20non-smoking subjects (N = 16) (BMI <30), healthy obese
non-smoking subjects (N = 15) (BMI >30), non-smoking pa-
tients with interstitial lung disease (ILD) (N = 15) (BMI <30)
and patients with emphysema (N = 16) (BMI < 30, FEV1/
FVC < 0.7) were investigated. However, patients with
a significant bronchodilator response (delta FEV1 ≥ 12%
and >200 mL) [12] in spirometry were excluded. The group
of patients with ILD (N = 15) consisted of 6 patients with
idiopathic pulmonary fibrosis (IPF), diagnosed according to
the ATS/ERS/JRS/ALAT 2011 guidelines [13]; 4 patients
with non-specific interstitial pneumonia (NSIP)/IPF-type
ILD related to a connective tissue disorder (1 with non-
specified collagenosis, 1 with mixed type of collagenosis, 1
with scleroderma and 1 with rheumatoid arthritis); 3 pa-
tients with sarcoidosis, 1 patient with fibrotic NSIP, and 1
patient with allergic alveolitis.
One patient with ILD was an ex-smoker with 20 pack-
years who had stopped smoking 3 years earlier. He had no
signs of obstruction according to the results of spirometry
and conventional constant-volume body plethysmography.
Other patients with ILD were lifelong non-smokers. Five
patients used peroral prednisolone, 3 patients’ triple-
therapy consisted of peroral prednisolone, azathioprine and
N-acetylcysteine. One patient used methotrexate, 1 N-acet-
ylcysteine, 1 cyclosporin and hydroxychloroquin, 1 peroral
prednisolone and azathioprine, 1 N-acetylcysteine and per-
oral prednisolone, and 2 did not take any specific medica-
tion for their ILD.
The obese subjects (N = 15) had no pulmonary dis-
eases, but 10 of them suffered from arterial hypertension
treated with different antihypertensive drugs and 4 used
diabetes medication.
The patients in the emphysema group showed a de-
creased diffusing capacity for carbon monoxide (< 74% of
predicted value) confirming emphysema. With the mean
value of 38.1% (SD 16.9) of predicted value [14], they suf-
fered from moderate emphysema. Most of them were
current smokers, but 5 had stopped smoking on average of
5.5 years earlier (Table 1). The patients with emphysema
(N = 16) also fulfilled the international criteria for COPD
[15]. They were smokers with symptoms of dyspnoea, their
post-bronchodilation FEV1/FVC ratio was lower than 0.7s and controls (mean (SD) and (range))
Emphysema, N =16 Obese, N = 15
10/6 4/11
2–85) 58.4 (13.7) (35–83) 95.01 (16.8) (78 – 134)
50 – 185) 168.9 (9.1) (155–183) 163.1 (9.2) (148 – 181)
0.8 – 28.4) 20.3 (3.81) (12.7 – 27.1) 35.5 (3.1 ) (30.8 – 41.8)
0 – 77) 62.7 (7.36) (44 – 74) 63.4 (9.2) (44 – 78)
10/5 0/0
41.4 (8.0) 0
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cording to a recent spirometric classification of COPD [16],
4 and 12 patients were classified as having moderate and
severe COPD, respectively. Two patients took no medica-
tion; however, all others used a combination of long-acting
beta-sympathomimetic and inhaled steroid (9 patients), tio-
tropium bromide monohydrate (6 patients), inhaled beclo-
methasone or budesonide (3 patients), peroral theophylline
(4 patients), peroral prednisolone, (2 patients) and ipratro-
pium bromide and/or salbutamol as a rescue medication
(3 patients).
The study protocol was approved by the Ethics Com-
mittee of Helsinki University Central Hospital, and all
participants gave their informed consent.
Methods
Spirometry was measured with a Medikro SpiroStar spir-
ometer (Medikro Kuopio, Finland) according to recent
international guidelines [17]. Bronchodilation testing was
performed using 0.4 mg of salbutamol aerosol (Ventoline®,
Glaxo UK) given with a spacer. Post-bronchodilator spir-
ometry was recorded 15 minutes after the salbutamol dose.
Diffusing capacity measurements were performed ac-
cording to international guidelines [18]. Vital capacity
(VC) was measured first, allowing standardization of
the inspiratory volume to 90% of individual maximal
VC [14]. The mean value of the parameters of two dif-
fusing capacity measurements was presented as the re-
sult. Measurements were corrected for haemoglobin
concentration.
The body plethysmographic measurements were per-
formed first in conventional constant-volume mode
(MasterScreen Body Version 4.3, Würzburg, Germany).
The atmospheric pressure was measured using a Vaisala
device (Vaisala, Finland). Flow-volume calibration ac-
cording to the three-flow protocol was performed with a
Jaeger 3 L calibration syringe. If the deviation of the reg-
istered volume was within ±3.5% for all flows, the cali-
bration was regarded as successful. Box verification/
calibration included two procedures. The time constant
of the box was verified to lie within the range of 4–
7 seconds. Box shift volume was calibrated following the
recommendations of the manufacturer.
For flow plethysmography, corresponding calibration
methods were applied. To allow flow-volume calibration
of the spirometer connected to the box chamber, the
box was set to the flow plethysmographic (transmural)
mode by removing the closure on the box wall hole and
closing the door of the box. The calibration pump strokes
were directed through the box chamber pneumotacho-
graph. A volume calibration was accepted if the stroke
volumes did not exceed the ±3.5% range.
All investigations were performed in conventional con-
stant volume mode first. The measurements of specificresistance breathing loops and functional residual capacity
(FRCpleth) were performed with a panting frequency
of 0.5 Hz [14]. The 4 second shutter manoeuvre (FRCpleth)
was linked to a maximal spirometric vital capacity
manoeuvre for determination of residual volume (RV) and
total lung capacity (TLC). The system automatically derived
total specific conductance (sGtot) from the breathing loops
and determined total respiratory resistance (Rtot).
In flow plethysmographic mode, the uncompressed
flow-volume curve at the chest wall and the compressed
flow-volume loops at the mouth were measured simul-
taneously. The differences between compression-free or
thoracic flows and corresponding compressed mouth
flows were regarded as rough estimates of the degree of
gas compression at levels of peak flow (PEF) and max-
imal expiratory flows at 75%, 50% and 25% of the
remaining forced vital capacity (MEF75, MEF50 and
MEF25). The volume reference was the same in both
thoracic and mouth flow measurements, i.e. the forced
vital capacity.
Statistical methods
The intra-individual comparisons of thoracic and mouth
flow at the levels of PEF, MEF75, MEF50 and MEF25
within the patient groups were investigated with paired
t-test. Between the groups, gas compression (measured
as the difference between thoracic and mouth flow at
different volume levels) was evaluated utilizing the non-
paired t-test. The comparisons of obese subjects with
other groups were adjusted for gender and age, the other
comparisons were adjusted for age and BMI. The signifi-
cance level of p-value was assessed after Bonferroni
correction.
Results
The results of spirometry, diffusing capacity and con-
stant volume body plethysmography for the patient
groups are summarized in Table 2. In ILD, restrictive
ventilatory impairments and reduction of diffusing cap-
acity were found. Reduced FEV1/FVC ratio, increased
Rtot and reduced sGtot were noted as signs of obstruc-
tion, and limited DLCOc and DLCOc/VA (KCOc) as
signs of emphysema. In obesity, low ERV and FRCpleth
were observed with a normal diffusing capacity.
A schematic presentation of gas flows during forced
expiration at the thorax and at the mouth is provided in
Figure 1, enabling the differences in gas compression for
each of the four groups to be visualized. The quantitative
results are given in Table 3. In all groups, a significant
difference between thoracic and mouth flows was found
at MEF50 (Table 3). In controls, a significant difference
was measured also at MEF75, in emphysema at PEF and
MEF75 and in obese subjects at MEF75 and as the only
group additionally at MEF25.
Table 2 Lung function data of patients and controls
Controls, N = 16 ILD, N = 15 p Emphysema, N = 16 p Obese, N = 15 p
Forced vital capacity (FVC) (L) 3.84 (0.94) 3.10 (1.08) NS 2.95 (0.98) NS 2.98 (0.69) NS
FVC (% of pred.) 98.56 (12.00) 80.27 (15.61) <0.005 76.75 (19.8) 0.003 91.13 (14.39) NS
Forced expiratory volume in 1 s (FEV1 (L) 2.93 (0.78) 2.46 (0.84) NS 1.24 (0.56) <0.001 2.36 (0.55) NS
FEV1 (% of pred.) 94.19 (15.58) 79.40 (14.49) NS 39.81 (15.19) <0.001 90.4 (16.27) NS
FEV1/FVC (%) 0.76 (0.07) 0.80 (0.08) NS 0.42 (0.11) <0.001 0.80 (0.05) NS
FEV1/FVC% (% of pred.) 94.38 (8.96) 99.67 (10.70) NS 52.38 (13.80) <0.001 99.6 (7.13) NS
Peak expiratory flow (PEF) (L/s) 7.80 (1.73) 7.43 (2.84) NS 3.43 (1.58) <0.001 6.6 (1.38) NS
PEF (% of pred.) 93.44 (16.08) 91.53 (24.56) NS 41.56 (18.86) <0.001 95.1 (21.09) NS
MEF50 (% of pred.) 73.38 (31.71) 81.60 (29.71) NS 12.25 (8.44) <0.001 73.9 (26.2) NS
MEF25 (% of pred.) 95.19 (52.52) 94.07 (51.77) NS 23.77 (14.62) <0.001 88.07 (30.92) NS
Rtot (% of pred.) 129.44 (37.02) 168.27 (60.32) NS 327.02 (176.1) 0.003 149.0 (36.8) NS
sGtot (% of pred.) 90.75 (29.48) 98.53 (48.37) NS 31.81 (16.25) <0.001 81.13 (24.1) NS
FRCpleth (Functional recidual capacity by plethysmograph (L) 3.86 (0.60) 2.77 (0.73) <0.001 5.17 (1.13) NS 2.46 (0.41) <0.001
FRCpleth (% of pred.) 104.62 (14.14) 77.07 (15.70) <0.001 129.2 (29.2) 0.007 89.5 (11.4) NS
TLC (Total lung capacity) (L) 6.88 (1.18) 5.12 (1.32) <0.001 7.38 (1.34) NS 5.43 (0.89) <0.005
TLC (% of pred.) 102.94 (12.08) 78.67 (13.66) <0.001 111.23 (14.00) NS 96.9 (8.79) NS
RV (residual capacity) (L) 2.49 (0.37) 1.8 (0.33) <0.001 3.86 (0.97) 0.002 2.02 (0.46) NS
RV (% of pred.) 97.1 (16.2) 73.67 (12.3) <0.001 150.8 (48.71) 0.004 95.2 (17.2) NS
ERV (Expiratory reserve volume) (L) 1.37 (0.63) 0.97 (0.47) NS 1.47 (0.56) NS 0.47 (0.33) <0.001
ERV (% of pred.) 121.4 (45.7) 85.8 (33.0) NS 102.8 (36.1) NS 71.3 (42.3) NS
Trapped air (TLCb – TLC He) (L) 0.82 (0.36) 0.82 (0.38) NS 2.08 (1.16) 0.004 0.71 (0.37) NS
DLCOc (Single-breath diffusing capacity for carbon monoxide) (% of pred.) 93.9 (11.3) 51.1 (15.1) <0.001 38.1 (16.9) <0.001 85.9 (12.7) NS
DLCOc/VA (Specific diffusing capacity) (% of pred.) 97.9 (8.4) 73.1 (15.3) <0.001 45.3 (16.9) <0.001 97.5 (15.8) NS
Conventional spirometric data; results from constant volume body plethysmography and diffusing capacity measurements are given, ((Mean (SD)). The p-values indicate comparisons between controls and patients
with pulmonary disease or obesity in non-paired t-test. Adjustments of t-tests have been performed as indicated in the Methods section. Bonferroni-corrected level of significance is p < 0.001. Pred. = predicted.
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Figure 1 Compressed (mouth) and compression-free (thoracic)
flow values at different expiratory flow levels. Compressed
(mouth flow) and uncompressed airflow (thoracic flow) during
forced expiration at peak expiratory flow level (PEF) and at different
levels of expired volume (MEF75, MEF50 and MEF25).
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http://www.biomedcentral.com/1471-2466/14/34At the level of PEF, the difference between thoracic
and mouth flows was significantly larger in patients with
emphysema than in controls or patients with ILD
(Figure 2).
When the patient groups were compared with each
other, ILD showed the lowest difference between thor-
acic and mouth flows at MEF75 (Figure 3).
At MEF50 and MEF25, the difference between thor-
acic and mouth flows was significantly larger in obese
subjects than in patients with emphysema (Figures 4 and 5).Discussion
Significant differences between thoracic and mouth
flows at forced expiration were observed in all patient
groups in this study, at least at the MEF50 level. Results
clearly indicate distortion of forced expiratory flow-
volume curves measured by conventional spirometric
methods. Some inter-individual variation and overlap-
ping between study groups occurred. However, signifi-
cant differences between thoracic and mouth flows can
be explained by differencies in pulmonary mechanics,
e.g. lung stiffness, obesity and decreased elastic recoil in
emphysema which cause different airways’ resistances.
Differences in flows were reduced in ILD at MEF75 and
increased in emphysema at PEF and MEF75. In obesity,
significant deviances were seen also at the level of
MEF25.
Mead [19] developed the volume displacement body
plethysmograph, and Jaeger and Otis [20] analysed vol-
ume displacement at the thorax and at the mouth and
found the latter to be lower. This difference in volumes
increased with increasing airway resistance, respiratory
rate and lung volume. Later on, a flow plethysmographwas developed, easily changeable from constant volume
mode to constant pressure mode (3).
In normal subjects, an increase of alveolar pressure in
forced expiration parallels a compression of intrabron-
chial gas, upstream of the equal pressure point [1].
Forced inspiration, on the contrary, induces a decom-
pression of alveolar gas. In bronchial obstruction, the in-
trabronchial gas compression in forced expiration has
been reported to be increased [4,5,9], explained by the
elevated airways resistance. Since in asthma the airways
obstruction may vary, only patients with stable pulmon-
ary diseases, without a significant bronchodilator re-
sponse measured with spirometry, were included in the
study.
The differences of thoracic and mouth flows in em-
physema patients at the level of PEF were larger than in
controls. PEF and MEF75 represent mostly characteris-
tics of proximal airways, and MEF50 of more peripheral
airways [12]. In emphysema, the support of bronchi is
limited because of the emphysematic process increasing
peripheral inhomogeneity and furthermore increasing
airway resistance, which may explain the findings. Our
results confirm earlier investigations in smokers [5] and
COPD [11]. In emphysematic COPD, the peripheral ob-
structions typically affect the MEF50 and MEF25 values.
In this study, MEF25 in patients with emphysema was
very low because of elevated airway resistance. The dif-
ferences of maximal expiratory flows measured by the
thoracic and mouth pneumotachographs at this flow
level were also elevated. In addition, in emphysematic
COPD probably lowered muscle force in forced expir-
ation may influence the expiratory flow values, although
this component was not investigated here.
In obesity, the differences between thoracic and mouth
flows also occurred at MEF25 level. Even though the dif-
ference at MEF25 was significant only in comparison
with emphysema, this finding is remarkable. Decreased
lung volume causes decreased airways calibers increas-
ing airways resistance, which might be the source of
this finding. The lungs have to work against increased
intra-abdominal pressure (not measured here) [21-25].
Trapped gas and low expiratory reserve volume also
contribute to unfavourable respiratory mechanics in
obesity. For most of the obese subjects the specific con-
ductance was in normal limits ≥46% of predicted value
[14], which indicates that no bronchial obstruction was
present in them.
The development of interstitial fibrosis decreases pul-
monary compliance and is associated with inhomogen-
eous gas exchange. This study revealed that patients
with ILD had unexpectedly low differences between
thoracic and mouth flows at the beginning of maximal
expiration. In ILD, elastic recoil forces are increased and
airways stiffened, which decreases airways resistance. In
Table 3 Gas compression at different levels of forced expiration according to patient group
Controls (N = 16) (L/s) M, RD p-value ILD (N = 15) (L/s) M, RD p-value Emphysema (N = 16) (L/s) M, RD p-value Obese (N = 15) (L/s) M, RD p-value
PEF mouth 7.62 (1.95) (5.0 – 11.2) 0.013 (−0.1 – 0.5) 7.33 (2.41) (3.2 – 12.4) - 0.007 (−0.02 – 0.2) 3.73 (1.82) (1.9 – 7.6) 0.11 (−0.25 – 0.46) 6.45 (1.01) (5.1 – 8.3) 0.03 (0 – 0.21)
NS 0.012 NSNSPEF thoracic 7.64 (1.96) (5.0 – 11.4) 7.33 (2.41) (3.2 – 12.4) 3.84 (1.85) (2.0 – 7.7) 6.48 (1.01) (5.1 – 8.3)
MEF75 mouth 6.40 (1.74) (4.4 – 9.9) 1.03 (−0.14 –3.55) 7.05 (2.44) (3.2 – 12.3) 0.073 (−0.85 – 2.15) 1.45 (1.13) (0.3 – 3.6) 1.26 (0.0 – 3.89) 5.6 (1.11) (4.0 – 8.3) 0.75 (0 – 1.84)
MEF75 thoracic 7.42 (1.86) (4.9 – 11.0) 0.002 7.1 (2.35) (3.2 – 12.2) NS 2.72 (1.93) (0.6 – 7.4) 0.001 6.31 (1.09) (4.8 – 8.3) 0.001
MEF50 mouth 3.62 (1.57) (1.5 – 8.1) 1.16 (−1,13 –3.33) 4.01 (1.12) (2.1 – 5.8) 1.5 (−0.63 – 3.78) 0.63 (0.37) (0.2 – 1.3) 0.3 (−0.13 – 1.39) 3.06 (1.01) (1.5 – 4.6) 1.33 (0.21 – 2.92)
MEF50 thoracic 4.78 (1.53) (2.8 – 8.2) 0.002 5.31 (2.00) (1.8 – 9.6) <0.001 0.93 (0.59) (0.2 – 2.2) 0.01 4.40 (1.01) (3.3 – 7.0) < 0.001
MEF25 mouth 1.18 (0.66) (0.5 – 3.0) 0.21 (−1.37 – 1.12) 1.18 (0.38) (0.5 – 2.0) 0.33 (−0.68 – 3.54) 0.24 (0.12) (0.1 – 0.4) 0.03 (−0.8 – 0.16) 0.77 (0.31) (0.4 – 1.2) 0.27 (−0.38 – 0.84)
MEF25 thoracic 1.38 (0.90) (0.3 – 4.2) NS 1.51 (1.01) (0.4 – 4.6) NS 0.27 (0.08) (0.1 – 0.4) NS 1.05 (0.43) (0.4 – 1.9) 0.006
Compressed (mouth) and uncompressed (thoracic measurement) flow values (mean, SD and range) at different levels of forced expiration; at peak expiratory flow (PEF), maximal expiratory flow when 75% of forced
vital capacity remains exhaled (MEF75), MEF 50 and MEF 25. Means (M) and ranges (RD) of the differences and the p-values of the paired t-test results between thoracic and mouth measurements in each group
are presented.
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Figure 2 Difference between thoracic and mouth flow at the
level of PEF. Level of significance after Bonferroni correction is
p <0.008.
Figure 4 Difference between thoracic and mouth flow at the
level of MEF50. Level of significance after Bonferroni correction is
p <0.008.
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bronchi is decreased or abolished.
Especially in several patients with ILD, we observed an
inverse behaviour between thoracic and mouth flows. It
is difficult to explain the reasons to that finding. It couldFigure 3 Difference between thoracic and mouth flow at the
level of MEF75. Level of significance after Bonferroni correction is
p <0.008.be possible that during forced expiration the upwards
movement of the diaphragm might be attenuated due to
stiff pulmonary tissue in ILD. Therefore, dynamic reduc-
tion of thoraco-abdominal volume during forced expir-
ation may be decreased thus counteracting the pressure
and volume displacements within the body box thereby
decreasing the flow measured through the wall of body
box (thoracic flow).
Another factor for the negative flow difference in ILD
might be an instrumental error. Assuming that no phase
shift occurs between measurements of mouth flow and
thoracic flow and no instrumental errors exist, mouth
flow exceeding thoracic flow would imply dilatation of
some gas compartments in the lungs or elsewhere in the
body during forced expiration.
As presented in Table 2 the total specific conductance
(sGtot) was the highest in ILD compared with the other
groups suggesting the least resistance. Based on the high
specific conductance the changes in intrathoracic pres-
sure, lung volume and air flow during forced expiration
are, probably, more abrupt in ILD patients than in other
patient groups. This might augment the effect of a pos-
sible phase shift between the measurements of mouth
flow and thoracic flow. As presented by Goldman et al.
[2] the volume change recorded by integrated flow
across the plethysmograph wall is slower than that mea-
sured at mouth because of a temporary loss of volume
during the initial decrease in plethysmographic air
Figure 5 Difference between thoracic and mouth flow at the
level of MEF25. Level of significance after Bonferroni correction is
p <0.008.
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stant of the mouth flow could be high enough to fit with
the compensation of the time constant of the box. In
ILD, the time constant of the mouth flow is low and an
incomplete correction of the box flow probably leads to
negative differences.
The patient groups are well defined, and typical func-
tional findings were made within each group. However,
finding suitable patients for the study was difficult. The
group of emphysema patients was on average older than
other groups. Patients with pulmonary fibrosis were
mostly on peroral steroids, therefore having tendency for
overweight. Locating lean patients with ILD was thus
challenging. In addition, it was challenging to find
healthy elderly obese non-smoking men. In conse-
quence, the BMI of patients with emphysema was lower
than that of other patient groups and healthy subjects.
The group of obese subjects mostly comprised women.
A small, non-significant difference in age was also
present between groups. To overcome these differences,
comparisons between all participants were adjusted for
these confounders, as indicated in the Methods section.
However, the subgroups were rather homogenous and
adjustments were not needed when comparisons within
these groups were performed. Most of the variables were
normally distributed. Because the available statistical
program did not allow adjustment for non-parametric
tests, parametric tests were used for all comparisons.
The results in non-parametric and parametric testingdid not differ significantly; therefore, no bias was likely
caused by this restriction.
We have used a panting frequency of 0.5 Hz because
the Finnish reference values for body plethysmography
[14] have been determined for this panting frequency.
Compared with medium or high panting frequencies,
there might be slight differences in the functional re-
sidual capacity (FRC) values [26]. Originally, Jaeger and
Otis (1964) [20] used spontaneous breathing and recom-
mended avoidance of panting in body plethysmographic
measurements.
Conclusion
In conclusion, patient groups with distinct respiratory
mechanics show different profiles of gas compression.
All groups had elevated differences between thoracic
and mouth flows in the mid-fraction of forced expiratory
manoeuvre. The remarkable difference in thoracic and
mouth flows found in emphysema is probably associated
with inhomogeneity of the lung and decreased elastic
forces increasing peripheral obstruction. The low differ-
ence between thoracic and mouth flows in ILD, can be
explained by increased elastic forces decreasing airway
resistance in the proximal airways.
Our results revealed remarkable levels of gas compres-
sion also in obesity in the middle and last parts of the
maximal expiratory manoeuvre. These findings may help
in the interpretation of conventional spirometric results,
especially in obese subjects. A decrease in forced expira-
tory flow in non-smoking healthy obese subjects is more
likely a result of gas compression than of real bronchial
obstruction.
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